ID: ALA3144127

Max Phase: Preclinical

Molecular Formula: C33H40N8O6

Molecular Weight: 644.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)Nc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C33H40N8O6/c1-21(2)28(40-31(44)27(20-22-10-5-3-6-11-22)39-29(42)23-12-7-4-8-13-23)32(45)38-26(14-9-19-36-33(34)35)30(43)37-24-15-17-25(18-16-24)41(46)47/h3-8,10-13,15-18,21,26-28H,9,14,19-20H2,1-2H3,(H,37,43)(H,38,45)(H,39,42)(H,40,44)(H4,34,35,36)/t26-,27-,28-/m0/s1

Standard InChI Key:  QQVNCBCBFNWLJX-KCHLEUMXSA-N

Associated Targets(non-human)

Trypsin I 1205 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 644.73Molecular Weight (Monoisotopic): 644.3071AlogP: 2.25#Rotatable Bonds: 16
Polar Surface Area: 223.94Molecular Species: BASEHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.69CX Basic pKa: 10.78CX LogP: 2.70CX LogD: 0.60
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.04Np Likeness Score: -0.37

References

1. Lu T, Tomczuk B, Illig CR, Bone R, Murphy L, Spurlino J, Salemme FR, Soll RM..  (1998)  In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors.,  (13): [PMID:9873397] [10.1016/s0960-894x(98)00290-x]

Source